Category Archives: Healthcare

PURDUE PHARMA BANKRUPTCY

Posted on October 7, 2019 by flpbaruchnewsletter

Bankruptcy filings on Thursday and Friday revealed that OxyContin maker Purdue Pharma sent $12 billion or $13 billion in profits to members of the Sackler family, the family that owns the closely-held company. This new testimony complicates the bankruptcy proceedings, … Continue reading →

Posted in Drugs, Healthcare | Leave a comment

ABBVIE AND ALLERGAN MERGER

Posted on October 7, 2019 by flpbaruchnewsletter

AbbVie and Allergan’s $63 billion merger is facing increased scrutiny from the Federal Trade Commission. Following outcry from advocacy and union groups, the FTC has issued a second letter to AbbVie and Allergan requesting more information. Advocacy groups claim both … Continue reading →

Posted in Acquisition, Healthcare | Leave a comment

CVS Health and Aetna Deal Faces Resistance

Posted on November 5, 2017 by flpbaruchnewsletter

With the announcement of CVS Health’s proposal to acquire Aetna, a health insurance company, for $66 billion, investors on both sides are becoming wary of whether or not this deal should be pursued despite CVS’ strong push for the deal … Continue reading →

Posted in Acquisition, Healthcare | Tagged , , , , , , , , | Leave a comment

MYLAN’S EPIPEN JOINS CONGRESS’ PUBLIC EYE OF RADICAL PRICE INCREASES

Posted on October 1, 2016 by flpbaruchnewsletter

Following last week’s congressional hearing of Mylan’s Epipen with the house committee on oversight and government reform, CEO, Heather Bresch was ridiculed by the public for alleging false profit margins and tax rates. Heather and her team said that after … Continue reading →

Posted in biotech, Congress, Congressional Hearing, Corporate News, Drugs, EpiPen, Healthcare, Heather Bresch, Insurance, Mylan, Price, tax, Uncategorized | Leave a comment